AstraZeneca PLC Eases Its Migraine With $302 Million Sale

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-astrazeneca.jpg" NAME"AstraZeneca PLC Eases Its Migraine With $302 Million Sale" ALT"AstraZeneca PLC Eases Its Migraine With $302 Million Sale"June 7, 2017By Alex Keown, BioSpace.com Breaking News StaffLONDON... Source: BioSpace

Continue ReadingAstraZeneca PLC Eases Its Migraine With $302 Million Sale

Bristol-Myers Squibb Loses $4.3 Billion in Market Value After ASCO Update

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-bristol-myers-squibb.jpg" NAME"Bristol-Myers Squibb Loses $4.3 Billion in Market Value After ASCO Update" ALT"Bristol-Myers Squibb Loses $4.3 Billion in Market Value After ASCO Update"June 7, 2017By Mark Terry, BioSpace... Source:…

Continue ReadingBristol-Myers Squibb Loses $4.3 Billion in Market Value After ASCO Update

<b>Ramaswamy</b> Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co.

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-roivant-vivek-ramaswamy.jpg" NAME"Ramaswamy Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co." ALT"Ramaswamy Launches Another New Biotech to Work on Phase III-Ready Drug From Merck…

Continue Reading<b>Ramaswamy</b> Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co.